Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1
Express Pharma
JUNE 19, 2025
Indian pharmaceutical companies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). For instance, India’s role as a major supplier of COVID-19 vaccines underscored its capabilities in high-volume sterile manufacturing (4).
104 
Let's personalize your content